<i>Acinetobacter Baumannii</i> Infection in Neurosurgery Intensive Care Unit and the Nursing Countermeasures_West China Medical Journal

Authors：

 LIXing-yu , SHIYan

Department of Neurosurgery, the First People's Hospital of Chengdu City, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

Keywords：

Neurosurgery intensive care unit; Acinetobacter baumannii; Infection condition; Nursing countermeasures

DOI：

10.7507/1002-0179.20140474

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the infection condition of Acinetobacter baumannii at the Neurosurgery Intensive Care Unit (NICU), and analyze the possible risk factors. Methods We retrospectively analyzed the clinical data of Acinetobacter baumannii infection patients with craniocerebral injury treated at the NICU between January 2011 and June 2013. We collected such information as infection patients' population distribution, infection site, invasive operations and patients' nurse-in-charge level and so on, and analyzed the possible risk factors for the infection. Results Thirty-one patients were infected with Acinetobacter baumannii, and they were mainly distributed between 60 and 80 years old. The main infection site was lower respiratory tract, followed in order by urinary tract, gastrointestinal tract, skin and soft tissue. The risk factors might be related to age, invasive operation, nurse working ability, etc. Conclusion The patients at the NICU are vulnerable to infection of Acinetobacter baumannii. Reducing invasive diagnosis and nursing procedures, providing optimal care, and carrying out specialized nurse standardization training may be the important means to effectively reduce the infection.

Citation： LIXing-yu, SHIYan. Acinetobacter Baumannii Infection in Neurosurgery Intensive Care Unit and the Nursing Countermeasures. West China Medical Journal, 2014, 29(8): 1552-1554. doi: 10.7507/1002-0179.20140474 Copy

1.	Mao YX, Liu GW, Wang L, et al. The impact of pulmonary Acineto bacter baumannii infection on the prognosis of inpatients in a neurological intensive care unit[J]. J Int Med Res, 2013, 41(4):1120-1126.
2.	中華人民共和國衛生部. 醫院感染診斷標準(試行)[J]. 中華醫學雜志, 2001, 81(5):314-320.
3.	陸文香. 鮑曼不動桿菌感染情況與耐藥分析[J]. 抗感染藥學, 2010, 7(2):129-131.
4.	陳伯義, 何禮賢, 俞云松, 等. 中國鮑曼不動桿菌感染診治與防控專家共識[J].中華醫學雜志, 2012, 92(2):76-85.
5.	Zarrulli R, Crispino M, Bagattini M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance[J]. J Clin Microbiol, 2004, 42(3):946-953.
6.	Falagas ME, Karveli EA. The changing global epidemiology of Acinetobacter baumannii infections:a development with major public health implications[J]. Clin Microbiol Infect, 2007, 13(2):117-119.
7.	Asik G. Current approaches to explain the virulence of Acinetobacter baumannii[J]. Mikrobiyol Bul, 2011(45):371-380.
8.	李秀, 段窮, 李威, 等. 735株鮑曼不動桿菌的耐藥性分析[J]. 中國實驗診斷學, 2011, 15(12):2155-2156.
9.	趙新亮, 申長虹, 甄自剛, 等. 神經外科術后顱內感染的臨床研究[J]. 中華醫院感染學雜志, 2006(3):277-231.
10.	Rodríguez-Hernández, MJ, Pachón J, Pichardo C, et al. Impenem, doxycyclin, and amikacin inmonotherapy and in combination in Acinetobacter baumanni experimental pneumonia[J]. J Antimicrob Chemother, 2000, 45(4):493-501.
11.	向軍, 孫珍夏, 俊星, 等. 燒傷患者氣管套管內鮑曼不動桿菌生物膜形成及特征研究[J].上海交通大學學報·醫學版, 2010, 30(5):562-565.
12.	Chen YY, Chi MM, Chen YC, et al. Using a criteria-based reminder to reduce use of indwelling urinary catheters and decrease urinary tract infections[J]. Am J Crit Care, 2013, 22(2):105-114.
13.	Yang YS, Lee YT, Huang TW, et al. Acinetobacter baumannii nosocomial pneumonia:is the outcome more favorable in non-ventilated than ventilated patients?[J]. BMC Infect Dis, 2013, 19(13):142-148.
14.	Reechaipichitkul W, Phondongnok S, Bourpoern J, et al. Causative agents and resistance among hospital-acquired and ventilator-associated pneumonia patients at Srinagarind Hospital, northeastern Thailand[J]. Southeast Asian J Trop Med Public Health, 2013, 44(3):490-502.
15.	Joung MK, Kwon KT, Kang CI, et al. Impact of inappropriate antimicrobial therapy on outcome in patients with hospital-acquired pneumonia caused by Acinetobacter baumannii[J]. J Infect, 2010, 61(3):212-218.
16.	Matsumoto T, Fujita M, Yoshimura C, et al. A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii[J]. Kansenshogaku Zasshi, 2010, 4(3):305-308.

1. Mao YX, Liu GW, Wang L, et al. The impact of pulmonary Acineto bacter baumannii infection on the prognosis of inpatients in a neurological intensive care unit[J]. J Int Med Res, 2013, 41(4):1120-1126.
2. 中華人民共和國衛生部. 醫院感染診斷標準(試行)[J]. 中華醫學雜志, 2001, 81(5):314-320.
3. 陸文香. 鮑曼不動桿菌感染情況與耐藥分析[J]. 抗感染藥學, 2010, 7(2):129-131.
4. 陳伯義, 何禮賢, 俞云松, 等. 中國鮑曼不動桿菌感染診治與防控專家共識[J].中華醫學雜志, 2012, 92(2):76-85.
5. Zarrulli R, Crispino M, Bagattini M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance[J]. J Clin Microbiol, 2004, 42(3):946-953.
6. Falagas ME, Karveli EA. The changing global epidemiology of Acinetobacter baumannii infections:a development with major public health implications[J]. Clin Microbiol Infect, 2007, 13(2):117-119.
7. Asik G. Current approaches to explain the virulence of Acinetobacter baumannii[J]. Mikrobiyol Bul, 2011(45):371-380.
8. 李秀, 段窮, 李威, 等. 735株鮑曼不動桿菌的耐藥性分析[J]. 中國實驗診斷學, 2011, 15(12):2155-2156.
9. 趙新亮, 申長虹, 甄自剛, 等. 神經外科術后顱內感染的臨床研究[J]. 中華醫院感染學雜志, 2006(3):277-231.
10. Rodríguez-Hernández, MJ, Pachón J, Pichardo C, et al. Impenem, doxycyclin, and amikacin inmonotherapy and in combination in Acinetobacter baumanni experimental pneumonia[J]. J Antimicrob Chemother, 2000, 45(4):493-501.
11. 向軍, 孫珍夏, 俊星, 等. 燒傷患者氣管套管內鮑曼不動桿菌生物膜形成及特征研究[J].上海交通大學學報·醫學版, 2010, 30(5):562-565.
12. Chen YY, Chi MM, Chen YC, et al. Using a criteria-based reminder to reduce use of indwelling urinary catheters and decrease urinary tract infections[J]. Am J Crit Care, 2013, 22(2):105-114.
13. Yang YS, Lee YT, Huang TW, et al. Acinetobacter baumannii nosocomial pneumonia:is the outcome more favorable in non-ventilated than ventilated patients?[J]. BMC Infect Dis, 2013, 19(13):142-148.
14. Reechaipichitkul W, Phondongnok S, Bourpoern J, et al. Causative agents and resistance among hospital-acquired and ventilator-associated pneumonia patients at Srinagarind Hospital, northeastern Thailand[J]. Southeast Asian J Trop Med Public Health, 2013, 44(3):490-502.
15. Joung MK, Kwon KT, Kang CI, et al. Impact of inappropriate antimicrobial therapy on outcome in patients with hospital-acquired pneumonia caused by Acinetobacter baumannii[J]. J Infect, 2010, 61(3):212-218.
16. Matsumoto T, Fujita M, Yoshimura C, et al. A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii[J]. Kansenshogaku Zasshi, 2010, 4(3):305-308.

West China Medical Journal

Acinetobacter Baumannii Infection in Neurosurgery Intensive Care Unit and the Nursing Countermeasures

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content